These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 947739)

  • 41. [Effect of 3-hydroxy-lup-20(29)en-23-28-dioic acid on rat experimental gastric ulcers].
    Zhang SR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):198-202. PubMed ID: 2150356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
    Oselladore D; Chierichetti SM; Norberto L; Vibelli C
    Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer.
    Schenk J; Schmack B; Rösch W; Domschke W
    Scand J Gastroenterol Suppl; 1980; 65():103-7. PubMed ID: 7010527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sodium carbenoxolone. A review].
    Rösch W
    Med Welt; 1976 Dec; 27(49):2393-6. PubMed ID: 1016388
    [No Abstract]   [Full Text] [Related]  

  • 45. Peptic ulcer disease: review and update.
    Levine D
    R I Med J (1976); 1982 Aug; 65(8):315-23. PubMed ID: 6755630
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of cytoprotective agents in the treatment of gastric ulcers.
    Lam SK
    Med J Aust; 1985 Feb; 142(3):S21-3. PubMed ID: 3881652
    [No Abstract]   [Full Text] [Related]  

  • 48. Bilateral recurrent parotid gland swelling after endoscopy.
    Shields HM; Soloway RD; Long WB; Weiss JB
    Gastroenterology; 1977 Jul; 73(1):164-5. PubMed ID: 324860
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of cimetidine-resistant gastric ulcer with carbenoxolone-sodium (author's transl)].
    Simon B; Kather H; Kommerell B
    Med Klin; 1979 Aug; 74(35):1250-3. PubMed ID: 492046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.
    Reed PI; Davies WA
    Am J Dig Dis; 1978 Feb; 23(2):161-5. PubMed ID: 341689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of ulcers with pirenzepin. Results from clinic and practice].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.
    Cook PJ; Vincent-Brown A; Lewis SI; Perks S; Jewell DP; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():93-101. PubMed ID: 7010531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experience with sodium carbenoxolone].
    Kunz O
    Med Klin; 1971 May; 66(22):822-5. PubMed ID: 5579276
    [No Abstract]   [Full Text] [Related]  

  • 55. Medical treatment of duodenal ulcer.
    Misiewicz JJ
    Schweiz Med Wochenschr; 1979 Apr; 109(16):578-83. PubMed ID: 373101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histamine H2 antagonists.
    Langman MJ
    Practitioner; 1979 Oct; 223(1336):500-5. PubMed ID: 523402
    [No Abstract]   [Full Text] [Related]  

  • 57. Electrical potential difference, sodium absorption and potassium secretion by the human rectum during carbenoxolone therapy.
    Tomkins AM; Edmonds CJ
    Gut; 1975 Apr; 16(4):277-84. PubMed ID: 1132803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Carbenoxolone in therapy resistant stomach and duodenal ulcer].
    Ustün F
    Med Welt; 1971 Sep; 39():1527-8. PubMed ID: 5095732
    [No Abstract]   [Full Text] [Related]  

  • 59. [Conservative therapy of gastric and duodenal ulcers].
    Gail K
    Dtsch Med Wochenschr; 1973 Oct; 98(41):1918-20. PubMed ID: 4758620
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.